Thank you for your reading and interest in the news Bahrain says anti-malarial drug proving effective in battling coronavirus and now with details
Hind Al Soulia - Riyadh - A top health official in Bahrain said on Tuesday that the use of an anti-malarial drug to treat existing cases of the coronavirus had proved effective in the kingdom.
Dr Mohammed Al Khalifa, chairman of the national medical team to address coronavirus, told the Bahrain News Agency that hydroxychloroquine had proved effective in the recovery of “a number" of cases.
The drug, which was discovered in 1934, lessened the proportion of the virus and contributed to the decline of its symptoms and reduced its complications, Dr Al Khalifa said.
Bahrain is one of the first countries in the world to use the drug to try and treat Covid-19.
The drug was designed as a basic treatment for malaria, rheumatoid arthritis and lupus.
Hydroxychloroquine was also found to be effective at treating Sars in the early 2000s.
There has been limited testing on the effectiveness on Covid-19 and doctors have warned against self-medication especially after the death of a man in Arizona who took Hydroxychloroquine.
Dr Al Khalifa said Bahrain used hydroxychloroquine on February 26, 2020, after discovering the first existing case of the virus in the country on February 24.
He said Bahrain’s national medical team used the drug after it was used to treating the infection in China and South Korea.
David Vazquez, a street performer dressed as the Joker, waits in hopes of pedestrians who will pay to take pictures with him in Mexico City. AP Photo
Pallbearers pull the coffin of a deceased person for a funeral ceremony into the cemetery of Grassobbio, Lombardy. AFP
American Airlines passenger planes crowd a runway where they are parked due to flight reductions to slow the spread of coronavirus disease. Reuters
People wearing face masks arrive at the South Municipal cemetery in Madrid. AFP
A youth artist S.F. paints a mural about the Covid-19 crisis on the roof of his building in Athens. AFP
A picture taken from the roof the Emile Muller Hospital shows tents of a military field hospital during its setting up in Mulhouse, eastern France. AFP
An elderly person with an undisclosed illness arrives on a stretcher, and is admitted to NYU Langone Health Center hospital. AFP
French soldiers prepare medical gear during the setting up of an intensive care unit at a military field hospital at the Emile Muller Hospital in Mulhouse, eastern France. AFP
A researcher works on a vaccine against the new coronavirus at the Copenhagen University research lab. AFP
The USNS Mercy, a Navy hospital ship, departs the Naval Station San Diego and heads to the Port of Los Angeles to aid local medical facilities dealing with coronavirus disease patients, in San Diego, California. Reuters
A man wearing a face mask displays a sign for takeaway services at an eatery after New South Wales began shutting down non-essential businesses and moving toward harsh penalties to enforce self-isolation as the spread of coronavirus disease reached a "critical stage" in Sydney, Australia. Reuters
A health worker vaccinates a woman against the flu, as advised by health officials to facilitate diagnosis for coronavirus, amid the coronavirus disease (COVID-19) outbreak, in Brasilia, Brazil. Reuters
But many are sceptical of the efficacy of the drug and say it is unsafe.
The chloroquine and hydroxychloroquine drugs are known collectively as chloroquine phosphate, which is also used to clean fish tanks.
While some countries have reported successful cases, top scientists, including White House coronavirus task force member Anthony Fauci, have called reports that hydroxychloroquine might work anecdotal and said they need further study before the pill’s use is encouraged.
Hydroxychloroquine, particularly when given with the antibiotic azithromycin, has received widespread attention following a controversial, small study of about 40 patients hospitalized with Covid-19 in France. In that study, the drug appeared to help clear the virus from the bodies of 26 patients who were given the medication, based on samples taken from nasal swabs. Experts have criticized the design of the study, calling it interesting but far from definitive.
A more recent report published by the Journal of Zhejiang University in China showed that patients who got the medicine didn’t fight off the new coronavirus more often than those who did not get the medicine.
The study involved just 30 patients. Of the 15 patients given the malaria drug, 13 tested negative for the coronavirus after a week of treatment. Of the 15 patients who didn’t get hydroxychloroquine, 14 tested negative for the virus.
The results of the study weren’t statistically significant.
US President Donald Trump said the drugs, which could be obtained on prescription in America, were potential game-changers in the fight against the virus.
But earlier on Tuesday, a man in his sixties died in the US after ingesting chloroquine phosphate. He was from Phoenix, Arizona.
His wife, also in her sixties, is in a critical condition after taking the chemical, said Banner Health, which treated the couple.
The wife told NBC news that they saw Mr Trump “on every channel”, and that he said that “that this was safe”.
On Monday, Jordan announced it was starting a clinical trial of hydroxychloroquine in patients with coronavirus, with test also being conducted in the US, Europe and China.
But health officials in Nigeria have issued a warning about chloroquine after three people in the country overdosed on it.
Updated: March 25, 2020 12:15 PM
These were the details of the news Bahrain says anti-malarial drug proving effective in battling coronavirus for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at The National and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
